EverydayArticle link

Understanding the Journeying through Dementia Program: What the Research Really Means for You

The Journeying through Dementia program is a structured, community-based intervention designed to help people in the early stages of dementia build self-management skills, independence, and confidence. While the program showed good participant engagement and some individual benefits, the largest UK clinical trial found it was not clinically effective at improving quality of life compared to usual care, and it was not cost-effective. This doesn't mean it's worthless—some people benefited greatly—but it does mean you should approach it with realistic expectations and combine it with other proven supports. Here we break down what the research actually says, what you can try instead, and how to make the best decisions for your family.

Key points

  • The Journeying through Dementia program was not found to be clinically effective or cost-effective in the largest UK trial—do not expect it to dramatically improve quality of life.
  • Some participants did benefit greatly, so it may still be worth trying as a short-term experiment, but monitor closely and be ready to switch.
  • Combine the program with other evidence-based supports: caregiver education, respite care, non-drug behavior management, and coordinated medical care.
  • Do not use the program as a substitute for medical treatment or for managing challenging behaviors like wandering—those need separate, specific strategies.
  • Prioritize your own self-care as a caregiver; your well-being directly affects the quality of care your loved one receives.
  • If the program is not available or not working, explore alternatives like the UCLA Alzheimer's and Dementia Care model, cognitive stimulation therapy, or local support groups.

What Is the Journeying through Dementia Program?

The Journeying through Dementia (JtD) program is a manualized, group-based intervention developed in the UK for people living with early-stage dementia. It consists of 12 weekly facilitated group sessions and four one-to-one sessions, all delivered in community settings by healthcare staff (often from secondary care). The goal is to promote self-management, independence, and self-efficacy—helping participants learn practical strategies to cope with memory changes, maintain daily activities, and stay socially connected. The program was tested in a large randomized controlled trial (RCT) involving 480 participants across 13 locations in England, with the primary outcome being Dementia-Related Quality of Life (DEMQOL) at 8 months after randomization.

What Did the Research Actually Find?

The RCT, published in Health Technology Assessment (2022), found that the JtD program did not lead to statistically significant improvements in quality of life compared to usual care. The incremental cost per quality-adjusted life-year (QALY) was estimated at -£202,857, with a very wide confidence interval, meaning there is considerable uncertainty about its cost-effectiveness. In plain terms, the program is unlikely to be a good value for the NHS or other payers. However, the study also noted that fidelity (how well the program was delivered as intended) was good, and some participants—a minority—reported significant benefits. Importantly, about 17% of intervention participants and 15% of control participants experienced at least one serious adverse event, but none were deemed related to the program. The researchers acknowledged limitations including recruiting a relatively active population, challenges in delivering the program consistently, and the possibility that existing outcome measures may not capture all meaningful changes.

What Does This Mean for You as a Caregiver?

If you're considering the JtD program for your loved one, the evidence suggests it is not a magic bullet. It may help some individuals, but on average it doesn't outperform standard care (which includes medication, needs assessment, and referrals). This doesn't mean you should dismiss it outright—some people in the trial described receiving real benefit, and the program is structured and supportive. However, you should not expect it to dramatically improve quality of life or save money. Instead, think of it as one possible option among many. The more important takeaway is that the research underscores the need for realistic expectations and a comprehensive approach: combining medical care, non-drug strategies, caregiver support, and community resources. The program's lack of proven cost-effectiveness also means you may want to explore other interventions that have stronger evidence, such as the UCLA Alzheimer's and Dementia Care program (which showed reduced hospitalizations, ED visits, and Medicare costs) or structured caregiver education programs.

General caregiving information, not medical advice. Check medications and major care changes with your clinician.

Step-by-step

  1. Confirm program availability and eligibility with the GP before enrolling.

  2. After 4–6 sessions, review a weekly log tracking mood, engagement, and function.

  3. Stop without guilt if no benefit or distress arises, and switch to stronger-evidence alternatives like Cognitive Stimulation Therapy or Singing for the Brain.

  4. Pair JtD with a coordinated care model including a nurse care manager and caregiver education, such as the UCLA program (12% fewer hospitalizations, 20% fewer ED visits, 40% less nursing home placement) or similar NHS models.

  5. Set family expectations upfront: 'Let's try this for a few weeks—it helps some, but the best study shows it doesn't work for everyone.'

  6. Prioritize your own wellbeing with respite care, a support group, and caregiver education.

What not to do

  • Do not expect guaranteed improvement—the largest UK trial found no average benefit on quality of life.

  • Do not rely on JtD for wandering, aggression, or crisis behaviors; use dedicated strategies for those issues.

  • Do not ignore the trial's 17% serious adverse event rate—seek medical attention for falls, acute distress, or medical issues during the program.

  • Do not use JtD as a substitute for medical care; continue all prescribed treatments and needs assessments.

  • Do not force a reluctant or anxious loved one to attend; explore one-to-one or home-based options instead.

  • Do not neglect your own health—caregiver burnout worsens outcomes for both, and JtD does not address caregiver needs.

Practical tools

  • Realistic Expectations Script

    A low-pressure script: 'We've found a program that helps some people with early dementia learn new ways to manage daily life. The research shows it doesn't work for everyone, so let's try it for a few weeks and see how you feel. If it's not helping, we'll stop and try something else.'

  • Weekly Check-In Log

    One-page log with four columns: Date, Mood (1–5), Engagement (low/medium/high), and Notes. Review after 4–6 sessions; consistently low scores signal the program may not be a fit.

  • Wandering Prevention Toolkit

    Since JtD does not address wandering, assemble: (1) door/window alarms, (2) GPS tracker (watch or pendant), (3) home modifications like slide bolts above eye level and disguised exit doors, (4) a recent photo and current ID kept on hand.

  • Stronger-Evidence Alternatives List

    Reference card: Cognitive Stimulation Therapy (CST) groups, 'Singing for the Brain' (Alzheimer's Society), structured exercise/walking groups, coordinated care models (e.g., UCLA Alzheimer's and Dementia Care program). Ask your memory service or social prescriber what is available locally.

Discuss with your clinician

Ask your doctor: 'Given the JtD trial results, is there a specific program you recommend that has stronger evidence for improving quality of life in early-stage dementia?'

Discuss: 'My loved one has early-stage dementia and we are considering the JtD program. Are there any medical reasons (e.g., recent stroke, severe anxiety, medication interactions) that would make this program unsuitable?'

If your loved one is on dementia medications (e.g., donepezil, rivastigmine), ask: 'Should we continue these medications while participating in the program? Are there any changes needed?'

If your loved one has a history of falls or other safety concerns, ask: 'What precautions should we take during the program, especially if it involves travel or group activities?'

If you are considering stopping the program because of lack of benefit, ask: 'Are there alternative interventions, such as cognitive stimulation therapy, that might be more effective for us?'

Related guides

Sources